1Lee EL, Feldman M. Gastritis and Gastropathies. In: Feld- man M, Friedman LS, Brandt LJ. Editors. Feldman: Sleisen- ger and Fordtran's Gastrointestinal and Liver Disease. 8th ed. Philadelphia: Saunders; 2006:1068-1083.
2Sundt TM, Compton CC, Malt RA. M6n6trier's disease. A trivalent gastropathy. Ann Surg 1988; 208:694-701.
3Scharschmidt BF. The naturalhistory of hypertrophic gas- trophy (Menetrier's disease). Report of a case with 16 year follow-up and review of 120 cases from the literature. Am J Med 1977; 63:644-652.
4Wolfsen HC, Carpenter HA, Talley NJ. Menetrier's disease: a form of hypertrophic gastropathy or gastritis? Gastroenter- ology 1993; 104:1310-1319.
5BlaCkstone MM, Mittal MK. The edematous toddler: a case of pediatric M6n6trier disease. Pediatr Emerg Care 2008; 24: 682-684.
6Gleeson EC, Mangan TF, Levy MJ. Endoscopic ultrasound and endoscopic mucosal resection features of a non-protein losing form of M~n6trier's disease. Clin Gastroenterol Hepatol 2008; 6:e24-e25.
7Eisenstat DD, Griffiths AM, Cutz E, Petric M, Drumm B. Acute cytomegalovirus infection in a child with M6n6trier's disease. Gastroenterology 1995; 109:592-595.
8Xiao S~, Hart J, Marked gastric foveolar hyperplasia associ- ated with active cytomegalovirus infection. Am J Gastroen- tero12001; 96:223-226.
9Yeaton P, Frierson HF. Octreotide reduces enteral protein losses in M6n6trier's disease. Am J Gastroenterol 1993; 88: 95-98.
10Ojeda E, Ruiz J, Cosme A, Lobo C. [Menetrier disease as- sociated with ulcerative colitis. Response to the treatment with octreotide. Review of the diagnostic criteria and etio- pathogenesis]. Gastroenterol Hepatol 1997; 20:175-179.
